@article{10944,
  keywords = {Humans, Retrospective Studies, England/epidemiology, *Nebulizers and Vaporizers, chronic obstructive pulmonary disease, Exacerbation, Ff/umec/vi, Healthcare cost, Sitt},
  author = {A. Ismaila and K. Rothnie and R. Wood and V. Banks and L. Camidge and A. Czira and C. Compton and R. Sharma and S. Millard and O. Massey and D. Halpin},
  title = {Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study},
  year = {2023},
  journal = {Respir Res},
  volume = {24},
  edition = {2023/09/26},
  number = {1},
  pages = {229},
  isbn = {1465-9921 (Print)1465-9921},
  doi = {10.1186/s12931-023-02523-1},
  note = {1465-993x
Ismaila, Afisi S
Orcid: 0000-0002-2876-8308
Rothnie, Kieran J
Orcid: 0000-0003-4279-1624
Wood, Robert P
Orcid: 0000-0002-6977-435x
Banks, Victoria L
Orcid: 0000-0002-0087-7641
Camidge, Lucinda J
Orcid: 0000-0001-8056-054x
Czira, Alexandrosz
Orcid: 0000-0002-3395-6186
Compton, Chris
Orcid: 0000-0002-7564-5343
Sharma, Raj
Millard, Shannon N
Orcid: 0000-0001-9161-4259
Massey, Olivia
Halpin, David M G
Orcid: 0000-0003-2009-4406
Journal Article
England
Respir Res. 2023 Sep 25;24(1):229. doi: 10.1186/s12931-023-02523-1.},
  language = {eng},
}